Latest Industry Trends & News

Recently Added

3/21/2019
NewsletterOrthopedic
Pacira Acquires Myoscience for up to $220M

Myoscience reported March 5 that it will be acquired by Pacira Pharmaceuticals. Myoscience’s iovera° cryoneurolysis system will become part of Pacira’s non-opioid pain management portfolio. Per the...

3/21/2019
NewsletterOrthopedic
Medacta, Geisinger Partner for Lifetime Guarantee on Knee Replacement

Medacta International and Geisinger announced March 13 that they are launching a pilot program for lifetime-guaranteed knee replacements, following the successful launch of a similar program for hi...

3/21/2019
NewsletterOrthopedic
Humana Launches Bundled Payment for Spine Fusion and Expands Program for THA, TKA

Humana reported March 12 that it is expanding its value-based orthopedic specialty care for Medicare Advantage members. First, it is launching a spinal fusion episode-based model that offers additi...

3/21/2019
NewsletterOrthopedic
Exactech Acquires XpandOrtho

Florida-based Exactech announced March 12 that it acquired XpandOrtho for an undisclosed amount. Exactech produces bone and joint devices and biologics, along with computer-assisted surgery technol...

3/21/2019
NewsletterOrthopedic
Axolotl Research Points to Spinal Cord Regeneration Possibilities

Researchers from the Marine Biological Laboratory published results in Nature Communications Biology on March 6 on axolotl genes that control spinal cord regeneration. After trauma, the gene c-Fos ...

3/21/2019
NewsletterOrthopedic
Yale Study Shows Conformis Custom Implants Save Money

Conformis, maker of the iTotal PS and iTotal CR knee implants, reported results of a study from the Yale School of Medicine and Baker Tilly Virchow Krause on Feb. 19. The researchers found that the...

3/21/2019
NewsletterOrthopedic
SWORD Health Publishes Positive Results for AI-Driven PT

A pair of studies published in Nature Scientific Reports and Journal of Medical Internet Research within the last 12 months reported superior results for SWORD Health’s AI-driven physical therapy p...

3/21/2019
BreakingOphthalmic
Aerie Begins Phase II Study of AR-1105 for ME Associated with RVO

Aerie Pharmaceuticals has begun patient dosing in a Phase II clinical trial of AR-1105, its investigational dexamethasone implant, in patients with macular edema due to retinal vein occlusion, the ...

3/21/2019
NewsletterOrthopedic
Coolief Trial Yields Positive Results

A prospective, randomized, multi-center trial with 177 patients was sponsored by Avanos Medical, the maker of Coolief, a cooled radiofrequency (RF) nerve ablation system. The study compared Coolief...

3/21/2019
BreakingOphthalmic
Aerpio’s Lead Candidate for Diabetic Retinopathy Fails in Phase IIb Study

Aerpio Pharmaceuticals’ lead candidate, AKB-9778, failed to meet its primary endpoint in a Phase IIb study for moderate to severe nonproliferative diabetic retinopathy (NPDR), the Cincinnati compan...

3/21/2019
BreakingOphthalmic
Bascom Palmer’s Wei Li Receives $9.12 Million NEI Grant to Develop Antibody for ROP

Wei Li, PhD, of the Bascom Palmer Eye Institute has received a $9.12 million National Eye Institute (NEI) grant to develop a drug to protect infants from retinopathy of prematurity (ROP), the Unive...

3/21/2019
NewsletterOrthopedic
Laser Spine Institute Closes Permanently

Tampa-based Laser Spine Institute closed its doors March 1. The company provided minimally invasive decompression and stabilization spine surgery in Tampa, Cincinnati, Scottsdale, and St. Louis. Th...

Past News Stories

3/21/2019
NewsletterOrthopedic
Myoscience Updates iovera° System

Myoscience announced Feb. 26 that it is launching the iovera° Smart Tip 309. The iovera° cryoneurolysis system uses liquid nitrous oxide (N2O) to generate temperatures of -88°C and 55 to 90 mm need...

3/21/2019
NewsletterOrthopedic
Seikagaku, Ono Publish Phase III Clinical Results for Knee OA Drug

Positive results were reported Feb. 19 from a Phase III clinical trial for the hyaluronic acid (HA) and NSAID combination drug ONO-5704/SI-613. The product was developed through a collaboration bet...

3/19/2019
NewsletterOphthalmic
Ophthalmic Company Revenues Increase 4.7 Percent in Q4-2018

Public company reports are in for Q4-2018, and overall ophthalmic revenues totaled $8.9 billion, an increase of 4.7 percent over the same quarter last year. The total includes Market Scope estimate...

3/19/2019
NewsletterOphthalmic
Surgeons Report 4.2 Percent Growth in US Ophthalmic Procedure Volume in Fourth Quarter

US ophthalmologists reported that ophthalmic procedures increased 4.2 percent in Q4-2018 compared with the same quarter last year, according to Market Scope’s latest surveys. Growth was sporadicall...

3/19/2019
NewsletterOphthalmic
India Honors Ophthalmic Heritage, Unveils Ambitious New Goal in DR

The All India Ophthalmological Society (AIOS) celebrated 200 years of Indian ophthalmology at its 77th annual conference, which was held Feb. 14-17 in Indore, India. Prof. S. Natarajan, MD, the new...

3/20/2019
NewsletterOphthalmic
Manual Small Incision Cataract Surgery Travels from India to America

Daniel Hutter, MD (US), told attendees at the All India Ophthalmological Conference (AIOC) in Indore how the Bascom Palmer Eye Institute started teaching manual small incision cataract surgery (MSI...

3/20/2019
NewsletterOphthalmic
Roche to Acquire Spark Therapeutics for $4.8 Billion

Roche will acquire Spark Therapeutics for $4.8 billion, paying a price of $114.50 per share, in an all-cash transaction, the companies announced Feb. 25. The move build’s on Roche’s hemophilia prog...

3/20/2019
NewsletterOphthalmic
China’s Crackdown on Health Agencies Opens Door for Global Ophthalmic Firms

China's massive overhaul of its health agencies is continuing the Communist Party's push to open the country to more health care therapies and technologies. The move is creating new opportu...

3/20/2019
NewsletterOphthalmic
Alcon Acquires PowerVision for $285 Million, Plus Potential Milestone Payments

Alcon has acquired PowerVision for an upfront payment of $285 million, Novartis announced March 18. Alcon also agreed to make additional payments based on regulatory and commercial milestones start...

3/20/2019
NewsletterOphthalmic
Eurazeo Acquires DORC from Montagu for €300 Million

Paris-based Eurazeo Capital has agreed to acquire Dutch Ophthalmic Research Center (DORC) from Montagu Private Equity, of London, for nearly €300 million ($339 million), the companies announced Mar...

3/20/2019
NewsletterOphthalmic
FDA Approves Aerie’s Rocklatan for Open-Angle Glaucoma, Ocular Hypertension

The US FDA has approved Aerie Pharmaceuticals’ Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or o...

3/20/2019
NewsletterOphthalmic
FDA Chief Scott Gottlieb, MD, Announces Resignation, Will Leave Post in April

US FDA Chief Scott Gottlieb, MD, has announced that he is resigning and will leave the agency in April, the Department of Health and Human Services announced March 5. Gottlieb, who has led the agen...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2019 Market Scope, LLC. All Rights reserved.